Dissemin is shutting down on January 1st, 2025

Published in

American Association for the Advancement of Science, Science Advances, 24(6), 2020

DOI: 10.1126/sciadv.aay7973

Links

Tools

Export citation

Search in Google Scholar

Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Nanoparticle-based thymulin gene therapy provides near-complete resolution of key pathology of chronic allergic asthma.